 | Up a level |
Molinari-Büchi, B.; Barth, J.; Janner, M.; Frey, P. (2010). Overweight and obesity in children: known facts and new trends. Revue médicale suisse, 6(249), pp. 1022-1025. Genève: Médecine & Hygiène
del Pozo, E.; Zapf, J.; Mackenzie, A. R.; Janner, M.; Perrelet, R.; Lippuner, K.; Mullis, P. (2009). Experimental arthritis: effect on growth parameters and total skeletal calcium. Growth hormone & IGF research, 19(5), pp. 442-446. Oxford: Elsevier 10.1016/j.ghir.2009.01.003
Janner, M.; Mullis, P. E. (2007). Impaired calcium homeostasis, clinical impact. Therapeutische Umschau, 64(5), pp. 271-275. Bern: Huber
Janner, M.; Mullis, P. E.; Flück, C. E. (2006). Is the metabolic syndrome a new childhood disease? Praxis - schweizerische Rundschau für Medizin, 95(13), pp. 493-500. Bern: Huber
Janner, M.; Mullis, P. E. (2005). Osteonpenia and pathological fractures in an adolescent with lactose intolerance and high oxalate intake. Monatsschrift Kinderheilkunde, 153(4), pp. 360-363. Springer-Verlag 10.1007/s00112-003-0773-3
Janner, M.; Knill, S. E.; Diem, P.; Zuppinger, K. A.; Mullis, P. E. (1994). Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study. European journal of pediatrics, 153(6), pp. 403-408. Berlin: Springer 10.1007/s004310050162
Mühlbauer, R. C.; Bauss, F.; Schenk, R.; Janner, M.; Bosies, E.; Strein, K.; Fleisch, H. (1991). BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. Journal of bone and mineral research, 6(9), pp. 1003-1011. Wiley-Blackwell
